ARK Invest Shifts From Big Tech To Crypto and AI With Major Stock Sales

• ARK Invest sold $45.6M in Meta and $27.8M in NVIDIA, reallocating funds to emerging sectors like AI and crypto.
• ARK invested nearly $4M in Tempus AI following its cancer biomarker research deal with Daiichi Sankyo.
• ARK added exposure to Bitmine while cutting positions in Block, Archer Aviation, and other tech firms.

ARK Invest has made a notable portfolio shift, moving funds away from major technology firms and toward crypto infrastructure and AI-driven healthcare.

The firm, led by Cathie Wood, has sold positions in companies like Meta and NVIDIA while adding exposure to newer sectors such as medical AI and digital assets.

Shift Away From Big Tech Holdings

ARK Invest reduced its exposure to large technology companies through several recent trades. The firm sold about $45.6 million worth of Meta shares and $27.8 million of NVIDIA stock. These sales mark a change in allocation as the firm adjusts its focus.

ARK INVEST’S GAME-CHANGING PIVOT: TECH OUT, CRYPTO IN

Cathie Wood’s ARK Invest has offloaded $45.6M in Meta $META and $27.8M in NVIDIA, redirecting capital to crypto infrastructure with Bitmine $BMNR and medical AI via Tempus. This bold rebalance signals a sharp focus on… https://t.co/IBw7JxgATI pic.twitter.com/yPGPXYqVlN

— CryptosRus (@CryptosR_Us) March 27, 2026

Meta has faced ongoing challenges, including job cuts and legal pressure. Reports noted that around 700 roles were reduced. At the same time, NVIDIA has seen strong performance, yet ARK chose to lock in gains and reallocate capital elsewhere.

The firm also trimmed positions in Block and sold shares in Roku and Teradyne. These moves show a broader reduction in exposure to established tech and fintech firms.

Increased Focus on Crypto Infrastructure

Alongside these sales, ARK Invest increased its exposure to crypto-related assets. The firm directed capital into Bitmine, a company linked to digital asset infrastructure. This step aligns with ARK’s long-term interest in blockchain technology.

Crypto markets have shown renewed activity, and institutional participation has grown.

ARK’s allocation suggests a belief that infrastructure providers may benefit from this trend. The firm has often supported decentralized finance and blockchain adoption.

While the exact size of the Bitmine purchase was not disclosed in detail, the move reflects a clear shift. Capital is being redirected from traditional tech into emerging digital asset platforms.

Expansion Into AI-Driven Healthcare

ARK also added to its position in Tempus AI, investing nearly $4 million across its funds. Tempus focuses on data-driven healthcare and uses artificial intelligence to improve clinical decisions.

The investment follows Tempus’s announcement of a partnership with Daiichi Sankyo.

The collaboration aims to use AI for biomarker discovery in cancer treatment. This approach may support more precise therapies and improve drug development outcomes.

Healthcare and AI remain key themes for ARK. The firm has stated in past updates that these sectors offer strong growth potential. Tempus fits within that strategy as it combines data, diagnostics, and machine learning.

Broader Portfolio Rebalancing Activity

ARK’s recent trades also included sales of Archer Aviation and Illumina.

The firm sold about $2.6 million worth of Archer Aviation shares. These reductions indicate a shift away from certain speculative and high-growth names.

Cathie Wood’s Ark Invest made major portfolio moves Wednesday, buying Tempus AI shares while selling Meta, Archer Aviation, and Block. The trades reflect Ark’s continued shift toward AI and healthcare technology.

Ark bought nearly $4 million worth of Tempus AI shares across… pic.twitter.com/beO0aQ7P53

— Benzinga (@Benzinga) March 26, 2026

Block was another company where ARK reduced its position. Block has focused on cost control and workforce reductions as part of its strategy. These changes may have influenced ARK’s decision to trim exposure.

Additional sales included Ionis Pharmaceuticals and Kratos Defense. The combined activity shows a broader rebalancing effort across multiple sectors.

Funds are being redirected toward areas tied to AI, healthcare, and digital assets.

These moves reflect ARK Invest’s ongoing effort to adjust its portfolio in line with emerging technologies. The firm continues to reposition capital as market conditions and innovation trends evolve.